Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 72162-2193

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 72162-2193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa Chemical Structure (Cls Tabs Carbi Str)

Chemical structure of Carbidopa monohydrate, depicting a benzene ring with hydroxyl groups, a side chain with a methyl and carboxyl group, and a hydrazine functional group, along with a hydration molecule (H2O).*

FDA Label Image

Levodopa Chemical Structure (Cls Tabs Levo Str)

Chemical structure diagram depicting the molecular structure of Carbidopa, one of the active ingredients in the Carbidopa and Levodopa extended-release tablet formulation by Bryant Ranch Prepack.*

FDA Label Image

Label (Lbl721622193)

Label for Carbidopa and Levodopa Extended-Release Tablets USP, 50 mg/200 mg, containing 100 tablets. The label includes storage instructions, dispensing requirements, and warnings to keep out of children's reach. Relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by ScieGen Pharmaceuticals, Inc. Also shown are barcode and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.